Ameritas Investment Partners
XENE icon

Ameritas Investment Partners’s Xenon Pharmaceuticals XENE Stock Holding History

Ameritas Investment Partners’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Buy
8,909
+1,771
+25% +$98.3K 0.01% 878
2026
Q1 		$415K Buy
7,138
+970
+16% +$44.7K 0.01% 904
2025
Q4 		$276K Sell
6,168
-390
-6% -$16.4K 0.01% 1070
2025
Q3 		$263K Sell
6,558
-1,200
-15% -$42.3K 0.01% 1082
2025
Q2 		$243K Buy
+7,758
New +$253K 0.01% 1182

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ameritas Investment Partners's XENE Position: Q2 2026 in Review

Ameritas Investment Partners increased its Xenon Pharmaceuticals (XENE) stake by 25% in Q2 2026, buying an estimated $98.3K and bringing the position to 8,909 shares worth $538K. The position accounts for 0.01% of the portfolio, ranked #878.

Ameritas Investment Partners first reported a position in XENE in Q2 2025 and has held it in 5 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Ameritas Investment Partners held 8,909 shares of Xenon Pharmaceuticals worth $538K as of Q2 2026.
  • Ameritas Investment Partners bought 1,771 Xenon Pharmaceuticals shares in Q2 2026, an estimated $98.3K.
  • Xenon Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #878 holding.
  • Ameritas Investment Partners first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.